查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612896

细胞治疗技术市场：按产品、製程、细胞类型和最终用户划分 - 2025-2030 年全球预测

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞治疗技术市值为194.8亿美元，预计到2024年将达到223.1亿美元，复合年增长率为14.63%，到2030年将达到506.9亿美元。

细胞治疗技术包括利用活细胞治疗或预防疾病的各种方法和生物技术。这些技术在肿瘤学、再生医学和血液学等多个领域展现了前景，提供了特异性而有效的个人化治疗选择。对细胞疗法的需求源自于其解决复杂医疗问题的潜力，特别是那些传统治疗方法无法解决的问题。开发应用范围广泛，最终用途范围很大，包括正在积极开发和部署这些治疗方法的生物技术公司、医院、研究机构和学术实验室。市场成长是由干细胞研究的进步、合作伙伴数量的增加以及对研究和研究的大量投资所推动的。成长的主要驱动因素包括慢性病的增加、资金筹措的增加以及加速临床试验和核准的有利监管环境。新的商机在于扩大 CAR-T 细胞的使用、增强基因编辑技术以及利用 3D 生物列印进行组织工程。公司可以透过投资创新伙伴关係关係、收购新兴新兴企业以及专注于生产扩充性来利用这些优势。然而，市场限制仍然存在，包括高昂的营运成本、严格的法律规范以及围绕基因改造和病人安全的伦理问题。这些挑战凸显了严格的临床检验和强有力的安全标准的必要性。此外，有限的生产能力和对专业医疗基础设施的需求也阻碍了广泛采用。需要创新的领域包括有针对性的输送系统、提高细胞活力和稳定性，以及透过自动化和人工智慧驱动的流程降低製造成本。探索同种异体细胞疗法，避免目前患者特异性（自体）细胞疗法的局限性，可能会增加可及性和市场范围。细胞治疗市场的本质是动态的、竞争激烈且快速发展的，因此公司必须保持敏捷、不断创新并有效应对监管环境以保持竞争力。

主要市场统计
基准年[2023] 194.8亿美元
预测年份 [2024] 223.1亿美元
预测年份 [2030] 506.9亿美元
复合年增长率（%） 14.63%

市场动态：揭示快速发展的细胞治疗技术市场的关键市场洞察

供需的动态交互作用正在改变细胞治疗技术市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球慢性病和感染疾病的增加
    • 增加细胞疗法生产设施的 GMP 认证
    • 透过投资细胞研究扩大政府倡议
  • 市场限制因素
    • 与细胞治疗技术相关的高成本
  • 市场机会
    • 持续关注个人化医疗
    • iPS 细胞作为替代 ESC 技术的出现
  • 市场挑战
    • 缺乏熟练的专业人员和严格的法律规范

波特五力：驾驭细胞治疗技术市场的策略工具

波特五力是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞治疗技术市场的外部影响

外部宏观环境因素在塑造细胞治疗技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解细胞治疗技术市场的竞争状况

对细胞治疗技术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质细胞治疗技术市场供应商绩效评估

FPNV定位矩阵是评估细胞治疗技术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定细胞治疗技术市场成功之路的策略分析与建议

对于旨在加强在全球市场的影响力的公司来说，细胞治疗技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病和感染疾病的发生率正在增加
      • 增加细胞疗法生产设施的 GMP 认证
      • 政府大力投资细胞研究
    • 抑制因素
      • 与细胞治疗技术相关的高成本
    • 机会
      • 持续关注个人化医疗
      • iPSC 的出现作为 ES 细胞的技术替代品
    • 任务
      • 缺乏熟练的专业人员和严格的法规结构
  • 市场区隔分析
    • 产品：巨量资料分析工具的出现将推动细胞治疗软体工具的采用
    • 过程：细胞保存技术的进步
    • 细胞类型：人类细胞在细胞和基因治疗中的使用越来越多
    • 最终用户：政府鼓励对研究机构投资的倡议
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞治疗技术市场：副产品

  • 消耗品
  • 装置
    • 细胞处理设备
    • 免洗设备
  • 软体

第七章细胞治疗技术市场：依製程分类

  • 细胞储存、分配和处理
  • 细胞处理
  • 过程监控和品管

第八章按细胞类型分類的细胞治疗技术市场

  • 动物细胞
  • 人体细胞
    • 分化细胞
    • 干细胞

第九章细胞治疗技术市场：依最终用户分类

  • 医疗保健和生命科学
  • 调查机构

第十章美洲细胞治疗技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太细胞治疗技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲细胞治疗技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Clade Therapeutics 宣布收购 Gadeta BV
    • 投资者投资细胞疗法生产，Start-UpsCerales 增资 2.55 亿美元
    • NewBiologix 筹集了 5000 万美元，用于推进基因和细胞疗法製造的新技术平台
  • 战略分析和建议

公司名单

  • Anterogen Co., Ltd.
  • Atara Biotherapeutics by FUJIFILM Corporation
  • Athersys, Inc.
  • Becton, Dickinson and Company
  • Bluebird Bio, Inc.
  • Bristol-Myers Squibb Company
  • Cellectis SA
  • Danaher Corporation
  • ElevateBio
  • Gamida Cell
  • GE Healthcare
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • Novartis AG
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Takeda Pharmaceutical Company Limited
  • Tego Science
  • Terumo Bct, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation
Product Code: MRR-034230D3E636

The Cell Therapy Technologies Market was valued at USD 19.48 billion in 2023, expected to reach USD 22.31 billion in 2024, and is projected to grow at a CAGR of 14.63%, to USD 50.69 billion by 2030.

Cell therapy technologies encompass a diverse range of methodologies and biotechnologies that harness living cells to treat or prevent diseases. These technologies hold promise across various domains such as oncology, regenerative medicine, and hematology, offering personalized treatment options that are both specific and effective. The necessity of cell therapy stems from its potential to address complex medical challenges, especially those unmet by traditional treatments. Applications are wide-ranging, with significant end-use scope in biotechnology firms, hospitals, research institutes, and academic labs actively developing and deploying these therapies. Market growth is bolstered by advancements in stem cell research, increasing partnership collaborations, and substantial investment inflows directed toward R&D. Key growth influencers include the rising prevalence of chronic diseases, increased funding, and favorable regulatory scenarios that accelerate clinical trials and approvals. Emerging opportunities lie in expanding the use of CAR-T cells, enhancing gene editing technologies, and leveraging 3D bioprinting for tissue engineering. Firms can capitalize on these by investing in innovative partnerships, acquiring emerging startups, and focusing on scalability of production. However, market limitations exist, such as high operational costs, stringent regulatory frameworks, and ethical concerns surrounding genetic modifications and patient safety. These challenges underscore the necessity for rigorous clinical validation and robust safety standards. Further, limited production capabilities and the need for specialized healthcare infrastructure can impede wide-scale adoption. Areas ripe for innovation include targeted delivery systems, improving cell viability and stability, and reducing manufacturing costs through automation and AI-driven processes. Research into allogenic cell therapy that circumvents current limitations of patient-specific (autologous) cell therapies could enhance accessibility and market reach. The nature of the cell therapy market is dynamic, with high competition and rapid technological evolution, emphasizing the importance for companies to remain agile, continuously innovate, and navigate regulatory landscapes effectively to maintain a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 19.48 billion
Estimated Year [2024] USD 22.31 billion
Forecast Year [2030] USD 50.69 billion
CAGR (%) 14.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Therapy Technologies Market

The Cell Therapy Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic diseases and infections globally
    • Rising GMP certifications for cell therapy production facilities
    • Surge in government initiatives through investments in cell-based research
  • Market Restraints
    • High costs associated with cell therapy technologies
  • Market Opportunities
    • Ongoing focus on personalized medicine
    • Emergence of iPSCs as an alternative to ESCs in technologies
  • Market Challenges
    • Dearth of skilled professionals and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Cell Therapy Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Therapy Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Therapy Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Therapy Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Therapy Technologies Market

A detailed market share analysis in the Cell Therapy Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Therapy Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Therapy Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Therapy Technologies Market

A strategic analysis of the Cell Therapy Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Equipment, and Software. The Equipment is further studied across Cell Processing Equipment and Single-Use Equipment.
  • Based on Process, market is studied across Cell Preservation, Distribution, & Handling, Cell Processing, and Process Monitoring & Quality Control.
  • Based on Cell Type, market is studied across Animal Cells and Human Cells. The Human Cells is further studied across Differentiated Cells and Stem Cells.
  • Based on End-User, market is studied across Healthcare & Life Science and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases and infections globally
      • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
      • 5.1.1.3. Surge in government initiatives through investments in cell-based research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cell therapy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing focus on personalized medicine
      • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
    • 5.2.2. Process: Advancements in cell preservation technologies
    • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
    • 5.2.4. End user: Government initiatives to propel investments in research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Therapy Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
    • 6.3.1. Cell Processing Equipment
    • 6.3.2. Single-Use Equipment
  • 6.4. Software

7. Cell Therapy Technologies Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Preservation, Distribution, & Handling
  • 7.3. Cell Processing
  • 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

  • 8.1. Introduction
  • 8.2. Animal Cells
  • 8.3. Human Cells
    • 8.3.1. Differentiated Cells
    • 8.3.2. Stem Cells

9. Cell Therapy Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare & Life Science
  • 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
    • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
    • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anterogen Co., Ltd.
  • 2. Atara Biotherapeutics by FUJIFILM Corporation
  • 3. Athersys, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bluebird Bio, Inc.
  • 6. Bristol-Myers Squibb Company
  • 7. Cellectis SA
  • 8. Danaher Corporation
  • 9. ElevateBio
  • 10. Gamida Cell
  • 11. GE Healthcare
  • 12. Gilead Sciences, Inc.
  • 13. JCR Pharmaceuticals Co., Ltd.
  • 14. Johnson & Johnson Services, Inc.
  • 15. Lonza Group Ltd.
  • 16. Merck KGaA
  • 17. Miltenyi Biotec B.V. & Co. KG
  • 18. Novartis AG
  • 19. Sartorius AG
  • 20. STEMCELL Technologies Inc.
  • 21. Takeda Pharmaceutical Company Limited
  • 22. Tego Science
  • 23. Terumo Bct, Inc.
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Vericel Corporation

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023